SERPING1 and hereditary angioedema: Intravenously administered plasma-derived C1-INH (pdC1-INH; Berinert; CSL Behring LLC; Kankakee, IL) and recombinant human C1-INH (rhC1-INH; Ruconest; Pharming Healthcare Inc.; Warren, NJ; Table 1) (23–37) are efficacious and well tolerated as on-demand treatment of HAE attacks (Table 2) (38–41).